SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001754429-24-000012
Filing Date
2024-10-28
Accepted
2024-10-28 17:59:22
Documents
1
Period of Report
2024-10-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 2968
  Complete submission text file 0001754429-24-000012.txt   4791
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Issuer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BIOXYTRAN, INC 233 NEEDHAM ST., SUITE 300 NEWTON MA 02464
Business Address
Utter Anders (Reporting) CIK: 0001818430 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35027 | Film No.: 241402154